Enzymatically Cleavable siRNA Prodrugs: a New Paradigm for the Intracellular Delivery of RNA-Based Therapeutics.
Prodrugs enlarged: An unprecedented synthesis of enzymatically cleavable siRNA prodrugs ("siRNN") has recently been reported. Targeting domain (TD)-functionalized siRNN released the parent siRNA after cellular uptake and triggered the RNA interference mechanism both in vitro and in vivo. The highlighted report could pave the way for prodrug-based approaches to overcome delivery-related limitations of nucleic acid therapeutics.